Searchable abstracts of presentations at key conferences in endocrinology

ea0050p024 | Adrenal and Steroids | SFEBES2017

Hyperandrogenism secondary to congenital portal hypertension

Yusuff Shafiq , Bhake Ragini C , Bremner Emma , Kieffer Nikki , Levy Miles J , Reddy Narendra L

Introduction: We report a rare case of hyperandrogenism associated with portal hypertension as a result of Alagille syndrome.Case report: 21-yr old female presented with primary amenorrhoea and mild hirsutism. There was no history of delayed puberty or acne. Past medical history: Alagille syndrome (biliary tree hypoplasia, liver disease, portal hypertension, splenomegaly, Barrett’s oesophagus and pulmonary stenosis). Drug ...

ea0050ep033 | Bone and Calcium | SFEBES2017

Vitamin D Toxicity & Undetectable Serum Levels – A Conundrum

Venugopal Vimal , Levy Miles J , Reddy Narendra L , Rahman Faizanur , Bhake Ragini C

59 year old woman with relapsing remitting multiple sclerosis (MS), not under Neurology follow-up was privately consulting a nutritionist based in Ireland and following the Coimbra protocol1 since December 2016. This included colecalciferol (1000-170000 IU/ day), vitamin B-complex and trace elements. Dose adjustments were advised during weekly skype consultations based on blood tests (via General Practitioner) and symptoms.<p class="abstex...

ea0050ep079 | Neuroendocrinology and Pituitary | SFEBES2017

Siadh associated with neuromyelitis optica involving hypothalamus

Papamargaritis Dimitris , Levy Miles J , Reddy Narendra L , Bhake Ragini C

A 21 year old Asian woman presented with relapse of Neuromyelitis Optica (NMO) spectrum disorder, diagnosed aged 16. She had headache, dizziness, right hand weakness and severe hyponatraemia (serum sodium [Na+] 116 [135–145]). Emesis, dominant in previous relapses, was absent – she was euvolaemic. Serum (Seosm) and urine (Uosm) osmolalities were 250 and 468 mosm/kg respectively, thyroid function ...

ea0050p024 | Adrenal and Steroids | SFEBES2017

Hyperandrogenism secondary to congenital portal hypertension

Yusuff Shafiq , Bhake Ragini C , Bremner Emma , Kieffer Nikki , Levy Miles J , Reddy Narendra L

Introduction: We report a rare case of hyperandrogenism associated with portal hypertension as a result of Alagille syndrome.Case report: 21-yr old female presented with primary amenorrhoea and mild hirsutism. There was no history of delayed puberty or acne. Past medical history: Alagille syndrome (biliary tree hypoplasia, liver disease, portal hypertension, splenomegaly, Barrett’s oesophagus and pulmonary stenosis). Drug ...

ea0050ep033 | Bone and Calcium | SFEBES2017

Vitamin D Toxicity & Undetectable Serum Levels – A Conundrum

Venugopal Vimal , Levy Miles J , Reddy Narendra L , Rahman Faizanur , Bhake Ragini C

59 year old woman with relapsing remitting multiple sclerosis (MS), not under Neurology follow-up was privately consulting a nutritionist based in Ireland and following the Coimbra protocol1 since December 2016. This included colecalciferol (1000-170000 IU/ day), vitamin B-complex and trace elements. Dose adjustments were advised during weekly skype consultations based on blood tests (via General Practitioner) and symptoms.<p class="abstex...

ea0050ep079 | Neuroendocrinology and Pituitary | SFEBES2017

Siadh associated with neuromyelitis optica involving hypothalamus

Papamargaritis Dimitris , Levy Miles J , Reddy Narendra L , Bhake Ragini C

A 21 year old Asian woman presented with relapse of Neuromyelitis Optica (NMO) spectrum disorder, diagnosed aged 16. She had headache, dizziness, right hand weakness and severe hyponatraemia (serum sodium [Na+] 116 [135–145]). Emesis, dominant in previous relapses, was absent – she was euvolaemic. Serum (Seosm) and urine (Uosm) osmolalities were 250 and 468 mosm/kg respectively, thyroid function ...

ea0059p074 | Clinical practice, governance &amp; case reports | SFEBES2018

A retrospective analysis of electronic endocrinology advice and guidance via NHS e-referral service at University Hospitals Leicester NHS Trust

Nadeem Sajjad , Aslam Waseem , Cave Helen , Bhake Ragini C , Levy Miles , Reddy Narendra L

Background: Electronic endocrinology advice and Guidance (e-Endo A&G) via NHS e-Referral Service was introduced at University Hospitals of Leicester NHS Trust (UHL) in March 2017 to address General Practitioners’ (GP) non-urgent endocrinology clinical concerns. Primary aims of the service, was to prevent inappropriate outpatient visits, avoid acute admissions and reducing length of time in resolution of queries.Objectives: To retrospectively eva...

ea0031p324 | Steroids | SFEBES2013

Continuous measurement of free cortisol profiles

Bhake Ragini C , Leendertz Jack A , Linthorst Astrid C E , Lightman Stafford L

In order to understand the significance of circadian and ultradian hormonal rhythms in man, both in health and disease, it is essential to be able to obtain multiple samples over extended periods, especially during the hours of sleep. The human automated blood sampling (HABS) system reported by Henley and colleagues can achieve this but is recommended for use in the setting of a clinical investigation unit which is its major drawback. For many diagnostic and scientific questio...

ea0077p47 | Metabolism, Obesity and Diabetes | SFEBES2021

Leicestershire wide steroid safety programme 2019-21 and effectiveness of electronic alert on prescription software in a tertiary centre

Ahsan Masato , Zaman Sajnin , Mifsud Roberta B , Reddy Narendra L , Bremner Emma , Barrowcliffe Mary , Bhake Ragini C , Levy Miles J

Background: Omission of steroids and unsafe steroid prescription in Adrenal insufficiency (AI) patients during intercurrent illness or surgery is unfortunately common, and can lead to adrenal crisis and potentially death. Anna Mitchell et al, New Castle-upon-Tyne have demonstrated potential use of electronic automation with steroid alerts to minimise human error for ensuring patient safety.Objectives: 1. Similar use of artificial intelligence wa...

ea0077p217 | Neuroendocrinology and Pituitary | SFEBES2021

Comparison of cardiovascular outcomes of radiotherapy vs non-radiotherapy cohort of Acromegaly patients

Mavilakandy Akash , Bhake Ragini C , Bremner Emma , Barrowcliffe Mary , Robertson Iain , Levy Miles J , Reddy Narendra L

Background: Radiotherapy is a third line treatment in Acromegaly. Pituitary radiotherapy (RT) is known to have cardiovascular complications (MI/IHD, CCF & CVA) due to radiation effects on normal pituitary and surrounding structures over and above the excess Growth hormone risk on metabolism (1).Objective: To compare RT vs non-RT treated Acromegaly cohorts’ cardiovascular (CV) outcomes in unselected consecutive Acromegaly patients.<p class="a...